AN1 0.00% 0.8¢ anagenics limited

Anna Nordin: Midkine in Advanced Prostate Cancer

  1. 551 Posts.
    lightbulb Created with Sketch. 173
    I've mentioned it before but bear with me, please, as the date of 18/01/2018 is coming closer. So let me link this again with a bit more info.

    As per past CDY announcements, Anna Nordin is one of Cellmid's known diagnostic collaborators in the field of prostate cancer.

    Anna Nordin: Midkine (MK/MDK) in Advanced Prostate Cancer - Biological Impact and Biomarker Potential.

    Link to Doctoral Thesis:
    https://gupea.ub.gu.se/handle/2077/53911

    It is currently featured on the university's current dissertations/disputations page (here with Google Translate, which works surprisingly well):
    https://translate.googleusercontent...tioner&usg=ALkJrhgrvy3dhHBobhwF7r-xJeDNANMp_Q
    Here are a few screenshots as the page will likely be updated in the future and the content might be lost.

    2017-12-26 14.22.07.png 2017-12-26 14.25.24.png 2017-12-26 14.26.54.png 2017-12-26 14.28.11.png 2017-12-26 14.30.52.png 2017-12-26 14.24.11.png

    The link to the doctoral thesis, however, should be permanent.
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
0.000(0.00%)
Mkt cap ! $3.690M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $336 42K

Buyers (Bids)

No. Vol. Price($)
3 1457234 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 340000 1
View Market Depth
Last trade - 14.19pm 12/07/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.